Healthcare >> Analyst Interviews >> December 18, 2000

Biopharmaceuticals: Andrew Milne – Dain Rauscher Wessels

ANDREW MILNE is a Vice President and Biotechnology Analyst at Dain Rauscher Wessels, a division of Dain Rauscher, Incorporated, covering biotechnology companies, including biopharmaceutical, specialty pharmaceutical and drug delivery companies. He was previously associated with Prudential Vector, Volpe Brown Whelan and BancBoston Robertson Stephens. Mr. Milne received a BA in Physiology and Chemistry from Michigan State University in East Lansing and a MS degree in Biotechnology from John Hopkins University. Profile
TWST: What are the key trends and the key issues that will impact

biopharmaceutical companies over the next 12 months?

Mr. Milne: Biopharmaceuticals is an exciting area of development of